Siponimod Patent Expiration

Siponimod is Used for treating multiple sclerosis. It was first introduced by Novartis Pharmaceuticals Corp in its drug Mayzent on Mar 26, 2019.

Siponimod Patents

Given below is the list of patents protecting Siponimod, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Mayzent	US11944602	Treatment of autoimmune disease in a patient receiving additionally a beta-blocker	Jul 24, 2036	Novartis
Mayzent	US12071402	Immunosuppressant formulations	Jan 05, 2032	Novartis
Mayzent	US8492441	Dosage regimen of an S1P receptor agonist	Nov 30, 2030	Novartis
Mayzent	US7939519	Immunosuppresant compounds and compositions	Aug 27, 2028	Novartis

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List